Allopurinol sodium

别嘌醇钠

Report date: 2026/03/30 17:02:26

Base Information

Drug NameAllopurinol sodium
Drug Alias NameAloprim
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionXanthine dehydrogenase inhibitors
TargetsXanthine dehydrogenase
Therapy Area/IndicationsHyperuricemiaGoutLeishmaniasis
Global Approved IndicationsHyperuricemiaGout
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1996/05/17
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMylan Nv
China Registration ClassN/A

Develop Information

Active CompaniesMylan Institutional Inc
Active IndicationsHyperuricemiaGout
Inactive IndicationsLeishmaniasis

Other Information

ATC CodeM04AA01